✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Dyne Therapeutics, Inc

Common Name
Dyne Therapeutics
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
263
Ticker
DYN
Exchange
NASDAQ/NGS
Description
Dyne Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapies for genetically driven neuromuscular diseases. The company utilizes its proprietary FORCE pla...

Dyne Therapeutics's Board Composition Data

Explore Dyne Therapeutics's board composition data, including the total number of board members and their breakdown by executive/non-executive status, independence, and gender.

Metric2026-04-23
Total Board Member Count
9a
Executive Board Member Count
1a
Non-executive Board Member Count
8a
Independent Board Member Count
8a
Non-independent Board Member Count
1a
Female Board Member Count
1a
Male Board Member Count
8a
Non-binary Board Member Count
0a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Dyne Therapeutics’s Board Composition Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Dyne Therapeutics's DEF 14A 2025